Skip to content

Boston Strategic Partners, Inc.

Healthcare strategy, economics, communication, regulatory affairs, financial advisory, and visual analytics

  • Home
  • About
    • BSP Professionals
    • Contact
  • Services
    • Business and Clinical Strategy
    • Health Economics and Outcomes Research
    • Medical and Technical Communications
    • Regulatory Strategy
    • Financial Advisory
  • EHR Data
    • Explore our Data
    • Selected Publications leveraging EHR Data
    • App Development
  • Connect
    • News
    • Publications
    • Blog Posts
    • Events Calendar
  • Real World Data
  • Careers

Tag: Prospective clinical trial

30Mar

Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo

Posted by katarinachinon March 30, 2017in Publications

Carr DB, McDonnell Moorehead T, Bouchard A, et al. Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo. Clin Ther. 2013;35(5):646-658. doi:10.1016/j.clinthera.2013.03.014.   View article

30Mar

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation

Posted by katarinachinon March 30, 2017in Publications

Kao DP, Davis G, Aleong R, et al. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail. 2013;15(3):324-333. doi:10.1093/eurjhf/hfs181. View article

30Mar

Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms

Posted by katarinachinon March 30, 2017in Publications

O’Connor CM, Fiuzat M, Carson PE, et al. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. Stoll M, ed. PLoS One. 2012;7(10):e44324. doi:10.1371/journal.pone.0044324. View article

30Mar

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

Posted by katarinachinon March 30, 2017in Publications

Merrigan M, Venugopal A, Mallozzi M, et al. Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production. J Bacteriol. 2010;192(19):4904-4911. doi:10.1128/JB.00445-10.   View article

Contact Us

4 Wellington St.
Suite 3
Boston, MA 02118
+1 617-446-3440
info@bostonsp.com

Discover

  • News
  • Electronic Health Record (EHR) Data
  • Publications
  • App Development
  • Events Calendar

Follow Us

  • LinkedIn
  • Twitter
This site uses cookies: Find out more.